LN-229 In Vitro High Content Screening (HCS) Assay

CAT#: ITS-1022-YF4086
Target Cell Organism: Human
Target Cell Name: LN-229
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
Assay Overview
This assay is to provide LN-229-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LN-229
Target Cell Organism
Human
Target Cell Background
The LN-229 cell line was established in 1979 from cells taken from a patient with right frontal parieto-occipital glioblastoma [PubMed. 10416987].
Related Diseases
Glioblastoma
Research Area
Oncology
Assay Name
In Vitro High Content Screening (HCS) Assay
Short Description
LN-229-cell based In Vitro High Content Screening (HCS) Assay
Assay Description
HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.
Assay Type
High-throughput Screening, High Content Screening and Reporter Gene Assays
For Research Use Only | Not For Clinical Use
Online Inquiry